{"name": "Private Formula International Holdings",
 "permalink": "private-formula-international-holdings",
 "crunchbase_url": "http://www.crunchbase.com/company/private-formula-international-holdings",
 "homepage_url": "http://www.drlewinns.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@drlewinns.com",
 "phone_number": "",
 "description": "pharmaceutical company",
 "created_at": "Wed Sep 30 21:07:25 UTC 2009",
 "updated_at": "Fri Oct 16 10:19:55 UTC 2009",
 "overview": "\u003Cp\u003EPrivate Formula International is a privately owned medium sized Australian company. It owns and distributes the Dr LeWinns brand through department stores and pharmacies nationally as well as\ninternationally. With 50+ staff based in Australia, the company is a leading innovator of anti-ageing skincare products and treatments providing its consumers with quality products that work at an\naccessible price point.\u003C/p\u003E\n\n\u003Cp\u003EPrivate Formula International head office is located at 460 Bay Street, Port Melbourne, Victoria. The company outsources its manufacturing activities through 3 overseas and 4 local suppliers. Private Formula has always been mindful of the potential impact on waste disposals in general and has been concerned on how the global environment changes could impact the future.\u003C/p\u003E\n\n\u003Cp\u003EPrivate Formula has recently being made aware of a structured organization in this area ie. National Packaging Covenant and fully supports its principles and goals hence, the company is now a signatory of the organization.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       35],
      "assets/images/resized/0006/2926/62926v1-max-150x150.jpg"],
     [[218,
       52],
      "assets/images/resized/0006/2926/62926v1-max-250x250.jpg"],
     [[218,
       52],
      "assets/images/resized/0006/2926/62926v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition":
  {"price_amount": 73400000.0,
   "price_currency_code": "USD",
   "term_code": "cash_and_stock",
   "source_url": "http://online.wsj.com/article/BT-CO-20090930-706362.html",
   "source_description": "Valeant Pharma To Buy Australian Skin-Care Company For $73.4M ",
   "acquired_year": 2009,
   "acquired_month": 9,
   "acquired_day": 30,
   "acquiring_company":
    {"name": "Valeant Pharmaceuticals International",
     "permalink": "valeant-pharmaceuticals-international",
     "image":
      {"available_sizes":
        [[[150,
           28],
          "assets/images/resized/0006/1320/61320v1-max-150x150.png"],
         [[250,
           47],
          "assets/images/resized/0006/1320/61320v1-max-250x250.png"],
         [[255,
           48],
          "assets/images/resized/0006/1320/61320v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "460 Bay Street",
    "address2": "",
    "zip_code": "3207",
    "city": "Port Melbourne",
    "state_code": null,
    "country_code": "AUS",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        100],
       "assets/images/resized/0006/2927/62927v1-max-150x150.jpg"],
      [[250,
        167],
       "assets/images/resized/0006/2927/62927v1-max-250x250.jpg"],
      [[450,
        300],
       "assets/images/resized/0006/2927/62927v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}